Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,835Open textbooks209Open-access articles1,406Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology182Genetics and Genomics170Neuroscience185Cardiovascular Medicine180Immunology142Pharmacology173Molecular Biology161Infectious Diseases150Rare and Inherited Diseases181Clinical Research173Anatomy and Physiology613Drugs and Chemicals621Psychiatry and Psychology185Public Health and Nutrition178Diagnostics and Medical Technology125Respiratory Medicine113Digestive System and Liver91Metabolism and Endocrine Disease177Bones, Joints, Muscles and Skin213Kidney, Urology and Women's Health173Eye, Ear, Nose and Throat55
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Kidney, Urology and Women's Health›Oligohydramnios

Continue where you left off ()

Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Oligohydramnios

Kidney, Urology and Women's Health · NLM MeSH · updated 2026-11-04 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 5 min read

A condition of abnormally low amniotic fluid volume.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (1,104 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

A condition of abnormally low amniotic fluid volume. Principal causes include malformations of fetal urinary tract; fetal growth retardation; gestational hypertension; nicotine poisoning; and prolonged pregnancy.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Where it fits in the MeSH classification

Broader topics
Pregnancy Complications

Related concepts

  • Amniotic Fluid
  • Urinary Tract
  • Fetal Growth Retardation
  • Gestational Hypertension
  • Prolonged Pregnancy

Research landscape

PubMed indexes 1,476 records tagged with the MeSH heading “Oligohydramnios” (counts retrieved 2026-11-04). 220 of them (14.9%) were published from 2020 onward, and the busiest period so far is through 1999 with 460 records.

Reviews account for 207 records (14.0%) and meta-analyses for 25. Randomized controlled trials number 42 (2.8%) as a share of all records on the topic.

PubMed records by publication periodthrough 1999: 460 records; 2000-2009: 424 records; 2010-2019: 372 records; 2020 onward: 220 records460through 19994242000-20093722010-20192202020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 1999460
2000-2009424
2010-2019372
2020 onward220
Share of records by publication typeReviews: 14.0 percent; Meta-analyses: 1.7 percent; Randomized controlled trials: 2.8 percentReviews14.0% (207)Meta-analyses1.7% (25)Randomized controlled trials2.8% (42)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 1,476 PubMed records
TypeRecordsShare
Reviews20714.0%
Meta-analyses251.7%
Randomized controlled trials422.8%

Method: PubMed query "Oligohydramnios"[MeSH Terms] with publication-type and date filters, retrieved 2026-11-04.

Reading the evidence in kidney, urology and women's health

Kidney, urinary and reproductive health research uses lab markers (such as creatinine), imaging, symptom scores and registry data on pregnancy and birth. Findings about pregnancy are especially sensitive to who was studied and when in pregnancy exposure occurred. Nothing on this page is advice about treatment, fertility or pregnancy; speak to a qualified clinician. Check the population, the outcome measured and whether the study accounted for other health differences between groups.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Indications and determinants of caesarean section delivery: Evidence from a population-based study in Matlab, Bangladesh
Begum T, Rahman A, Nababan H, Hoque DME, Khan AF, Ali T, et al.
2017Research article
Design not recorded in structured metadata
86cc by
PMID 29155840 · DOI · PMC5695799
Revisiting the role of first trimester homocysteine as an index of maternal and fetal outcome
Mascarenhas M, Habeebullah S, Sridhar MG
2014Research article
Design not recorded in structured metadata
36cc by
PMID 24883207 · DOI · PMC4027023
Oligohydramnios: a prospective study of fetal, neonatal and maternal outcomes in low-middle income countries
Figueroa L, McClure EM, Swanson J, Nathan R, Garces AL, Moore JL, et al.
2020Randomized controlled trial
Design not recorded in structured metadata
30cc by
PMID 32000798 · DOI · PMC6993413
Association of neonatal and fetal malformations with polyhydramnios and oligohydramnios - introduction of a new "association factor"
Beke A, Simonyi A
2025Research article
Design not recorded in structured metadata
1cc by
PMID 40610944 · DOI · PMC12225433

Indications and determinants of caesarean section delivery: Evidence from a population-based study in Matlab, Bangladesh [1]

Research article Begum T, Rahman A, Nababan H, Hoque DME, Khan AF, Ali T, et al. · · 2017 · cited 86 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Background and methodsCaesarean section (C-section) is a major obstetric intervention for saving lives of women and their newborns from pregnancy and childbirth related complications.
Closing excerpt
Routine monitoring of clinical indication of C-section in public and private facilities is needed to ensure rational use of the procedure.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (312 words)

Background and methodsCaesarean section (C-section) is a major obstetric intervention for saving lives of women and their newborns from pregnancy and childbirth related complications. Un-necessary C-sections may have adverse impact upon maternal and neonatal outcomes. In Bangladesh there is paucity of data on clinical indication of C-section at population level. We conducted a retrospective study in icddr,b Health and Demographic Surveillance System (HDSS) area of Matlab to look into the indications and determinants of C-sections. All resident women in HDSS service area who gave birth in 2013 with a known birth outcome, were included in the study. Women who underwent C-section were identified from birth and pregnancy files of HDSS and their indication for C-section were collected reviewing health facility records where the procedure took place, supplemented by face-to-face interview of mothers where data were missing. Indications of C-section were presented as frequency distribution and further divided into different groups following 3 distinct classification systems. Socio-demographic predictors were explored following statistical method of binary logistic regression.FindingsDuring 2013, facility delivery rate was 84% and population based C-section rate was 35% of all deliveries in icddr,b service area. Of all C-sections, only 1.4% was conducted for Absolute Maternal Indications (AMIs). Major indications of C-sections included: repeat C-section (24%), foetal distress (21%), prolonged labour (16%), oligohydramnios (14%) and post-maturity (13%). More than 80% C-sections were performed in for-profit private facilities. Probability of C-section delivery increased with improved socio-economic status, higher education, lower birth order, higher age, and with more number of Antenatal Care use and presence of bad obstetric history. Eight maternal deaths occurred, of which five were delivered by C-section.ConclusionsC-section rate in this area was much higher than national average as well as global recommendations. Very few of C-sections were undertaken for AMIs. Routine monitoring of clinical indication of C-section in public and private facilities is needed to ensure rational use of the procedure.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 29155840 · DOI · PMC5695799

Revisiting the role of first trimester homocysteine as an index of maternal and fetal outcome [2]

Research article Mascarenhas M, Habeebullah S, Sridhar MG · · 2014 · cited 36 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
AIM.
Closing excerpt
gov CTRI/2013/02/003441.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (182 words)

AIM. To revisit the role of first trimester homocysteine levels with the maternal and fetal outcome. METHODS. This was a cohort study comprising 100 antenatal women between 8 and 12 weeks of gestation. Serum homocysteine levels were checked after overnight fasting. RESULTS. There were significantly elevated homocysteine levels among women with prior history of hypertensive disorders of pregnancy and prior second or third trimester pregnancy losses. There was no significant difference in homocysteine levels among women with previous gestational diabetes mellitus, preterm deliveries, or fetal malformations. Homocysteine levels were significantly elevated in those who developed hypertensive disorder of pregnancy, oligohydramnios, and meconium stained amniotic fluid, had a pregnancy loss, or delivered a low birth weight baby. There was no significant difference in homocysteine levels for those who developed gestational diabetes mellitus. CONCLUSIONS. Increased first trimester serum homocysteine is associated with history of pregnancy losses, hypertensive disorders of pregnancy, and preterm birth. This is also associated with hypertensive disorders of pregnancy, pregnancy loss, oligohydramnios, meconium stained amniotic fluid, and low birth weight in the current pregnancy. This trial is registered with ClinicalTrials.gov CTRI/2013/02/003441.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 24883207 · DOI · PMC4027023

Oligohydramnios: a prospective study of fetal, neonatal and maternal outcomes in low-middle income countries [3]

Randomized controlled trial Figueroa L, McClure EM, Swanson J, Nathan R, Garces AL, Moore JL, et al. · · 2020 · cited 30 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundOligohydramnios is a condition of abnormally low amniotic fluid volume that has been associated with poor pregnancy outcomes.
Closing excerpt
Trial registrationNCT01990625.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (345 words)

BackgroundOligohydramnios is a condition of abnormally low amniotic fluid volume that has been associated with poor pregnancy outcomes. To date, the prevalence of this condition and its outcomes has not been well described in low and low-middle income countries (LMIC) where ultrasound use to diagnose this condition in pregnancy is limited. As part of a prospective trial of ultrasound at antenatal care in LMICs, we sought to evaluate the incidence of and the adverse maternal, fetal and neonatal outcomes associated with oligohydramnios.MethodsWe included data in this report from all pregnant women in community settings in Guatemala, Pakistan, Zambia and the Democratic Republic of Congo (DRC) who received a third trimester ultrasound as part of the First Look Study, a randomized trial to assess the value of ultrasound at antenatal care. Using these data, we conducted a planned secondary analysis to compare pregnancy outcomes of women with to those without oligohydramnios. Oligohydramnios was defined as measurement of an Amniotic Fluid Index less than 5 cm in at least one ultrasound in the third trimester. The outcomes assessed included maternal morbidity and fetal and neonatal mortality, preterm birth and low-birthweight. We used pairwise site comparisons with Tukey-Kramer adjustment and multivariable logistic models using general estimating equations to account for the correlation of outcomes within cluster.ResultsOf 12,940 women enrolled in the clusters in Guatemala, Pakistan, Zambia and the DRC in the First Look Study who had a third trimester ultrasound examination, 87 women were diagnosed with oligohydramnios, equivalent to 0.7% of those studied. Prevalence of detected oligohydramnios varied among study sites; from the lowest of 0.2% in Zambia and the DRC to the highest of 1.5% in Pakistan. Women diagnosed with oligohydramnios had higher rates of hemorrhage, fetal malposition, and cesarean delivery than women without oligohydramnios. We also found unfavorable fetal and neonatal outcomes associated with oligohydramnios including stillbirths (OR 5.16, 95%CI 2.07, 12.85), neonatal deaths ConclusionsOligohydramnos was associated with worse neonatal, fetal and maternal outcomes in LMIC. Further research is needed to assess effective interventions to diagnose and ultimately to reduce poor outcomes in these settings.Trial registrationNCT01990625.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 32000798 · DOI · PMC6993413

Association of neonatal and fetal malformations with polyhydramnios and oligohydramnios - introduction of a new "association factor" [4]

Research article Beke A, Simonyi A · · 2025 · cited 1 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundOur aim was to investigate the association of different neonatal and fetal anatomical abnormalities with polyhydramnios or oligohydramnios during prenatal ultrasonography.
Closing excerpt
In the case of polyhydramnios, fetal echocardiography is recommended.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (265 words)

BackgroundOur aim was to investigate the association of different neonatal and fetal anatomical abnormalities with polyhydramnios or oligohydramnios during prenatal ultrasonography.MethodsIn our study, we processed prenatal sonographic and postnatal neonatal clinical and pathological data from 2,622 fetuses with malformations over a 12-year period. We investigated the association of neonatal and fetal abnormalities with polyhydramnios or oligohydramnios. To characterize the prevalence of association between a given disorder and polyhydramnios or oligohydramnios, we used our proprietary "association factor" (AF) for statistical calculations.ResultsAmniotic fluid volume abnormalities were most frequently detected in urogenital, abdominal, and abdominal wall anomalies. In urogenital anomalies, amniotic fluid volume abnormalities were found in more than half of the fetuses, 54.86% (oligohydramnios 34.72%, polyhydramnios 20.14%). In abdominal and abdominal wall anomalies, 43.82% of fetuses had abnormalities in the volume of amniotic fluid (polyhydramnios 31.44%, oligohydramnios 12.38%). Overall, we found abnormalities in the volume of amniotic fluid in over 30% of the fetuses with craniospinal, thoracic and pulmonary anomalies, limb anomalies, and ossification disorders. In craniofacial and cardiovascular anomalies, amniotic fluid volume abnormalities were only detectable in around 20%. For polyhydramnios, the "Association Factor" (AF) was very high for craniospinal, abdominal, and abdominal wall disorders, and it was high for cardiovascular, urogenital, limb, and ossification disorders. For oligohydramnios, the association factor (AF) was very high for urogenital disorders.ConclusionsIf the amniotic fluid volume during ultrasonography is less or more than average, special attention should be paid to the ultrasound examination of the fetus' urogenital system, abdominal organs, skull, spine, chest, lungs, as well as limbs and skeletal system. In the case of polyhydramnios, fetal echocardiography is recommended.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 40610944 · DOI · PMC12225433

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Oligohydramnios in complicated and uncomplicated pregnancy: a systematic review and meta-analysis [5]
    Rabie N, Magann E, Steelman S, Ounpraseuth S · Ultrasound Obstet Gynecol · 2017 · cited 77 times (Europe PMC)
  • Research article Definition, diagnosis and management of fetal lower urinary tract obstruction: consensus of the ERKNet CAKUT-Obstructive Uropathy Work Group [6]
    Capone V, Persico N, Berrettini A, Decramer S, De Marco EA, De Palma D, et al. · Nat Rev Urol · 2022 · cited 57 times (Europe PMC)
  • Research article Association and prediction of amniotic fluid measurements for adverse pregnancy outcome: systematic review and meta-analysis [7]
    Morris RK, Meller CH, Tamblyn J, Malin GM, Riley RD, Kilby MD, et al. · BJOG · 2014 · cited 56 times (Europe PMC)
  • Research article Amniotic fluid abnormalities [8]
    Harman CR · Semin Perinatol · 2008 · cited 56 times (Europe PMC)
  • Research article Amniotic fluid index versus single deepest vertical pocket as a screening test for preventing adverse pregnancy outcome [9]
    Nabhan AF, Abdelmoula YA · Cochrane Database Syst Rev · 2008 · cited 52 times (Europe PMC)
  • Research article A review of amniotic fluid dynamics and the enigma of isolated oligohydramnios [10]
    Sherer DM · Am J Perinatol · 2002 · cited 50 times (Europe PMC)

References

  1. Begum T, Rahman A, Nababan H, Hoque DME, Khan AF, Ali T, et al.. Indications and determinants of caesarean section delivery: Evidence from a population-based study in Matlab, Bangladesh. . 2017. PMID 29155840 · DOI · PMC5695799
  2. Mascarenhas M, Habeebullah S, Sridhar MG. Revisiting the role of first trimester homocysteine as an index of maternal and fetal outcome. . 2014. PMID 24883207 · DOI · PMC4027023
  3. Figueroa L, McClure EM, Swanson J, Nathan R, Garces AL, Moore JL, et al.. Oligohydramnios: a prospective study of fetal, neonatal and maternal outcomes in low-middle income countries. . 2020. PMID 32000798 · DOI · PMC6993413
  4. Beke A, Simonyi A. Association of neonatal and fetal malformations with polyhydramnios and oligohydramnios - introduction of a new "association factor". . 2025. PMID 40610944 · DOI · PMC12225433
  5. Rabie N, Magann E, Steelman S, Ounpraseuth S. Oligohydramnios in complicated and uncomplicated pregnancy: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2017. PMID 27062200 · DOI
  6. Capone V, Persico N, Berrettini A, Decramer S, De Marco EA, De Palma D, et al.. Definition, diagnosis and management of fetal lower urinary tract obstruction: consensus of the ERKNet CAKUT-Obstructive Uropathy Work Group. Nat Rev Urol. 2022. PMID 35136187 · DOI
  7. Morris RK, Meller CH, Tamblyn J, Malin GM, Riley RD, Kilby MD, et al.. Association and prediction of amniotic fluid measurements for adverse pregnancy outcome: systematic review and meta-analysis. BJOG. 2014. PMID 24738894 · DOI
  8. Harman CR. Amniotic fluid abnormalities. Semin Perinatol. 2008. PMID 18652930 · DOI
  9. Nabhan AF, Abdelmoula YA. Amniotic fluid index versus single deepest vertical pocket as a screening test for preventing adverse pregnancy outcome. Cochrane Database Syst Rev. 2008. PMID 18646160 · DOI · PMC6464731
  10. Sherer DM. A review of amniotic fluid dynamics and the enigma of isolated oligohydramnios. Am J Perinatol. 2002. PMID 12152144 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-11-04; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-11-04.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • Fetal MacrosomiaMetabolism and Endocrine Disease
  • PolyhydramniosKidney, Urology and Women's Health
  • Pre-EclampsiaKidney, Urology and Women's Health
  • Fetal Alcohol Spectrum DisordersKidney, Urology and Women's Health
  • Pregnancy ComplicationsKidney, Urology and Women's Health
  • Premature BirthKidney, Urology and Women's Health

All 73 articles in Kidney, Urology and Women's Health →

At a glance

1,476
PubMed records on this heading
15%
published since 2020
207
review articles
42
randomized trials
10
verified references below

Counts come from PubMed on 2026-11-04; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • Fetal MacrosomiaMetabolism and Endocrine Disease
  • PolyhydramniosKidney, Urology and Women's Health
  • Pre-EclampsiaKidney, Urology and Women's Health
  • Fetal Alcohol Spectrum DisordersKidney, Urology and Women's Health
  • Pregnancy ComplicationsKidney, Urology and Women's Health

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Rights and removal requests · Legal · Support